Home

IAN F SMITH

CIK 1197032 · Chief Executive Officer · last filed 2026-07-07

IAN F SMITH is a Chief Executive Officer who has filed 150 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for SLDB, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$163.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $40.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.67M

Companies

9

Total Filings

150

Lifetime Open-Market Net

-$163.95M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLDB Director 138,145 $8.56 $1.18M $0 30 2026-07-07
FHTX Director — $6.24 — $0 8 2026-06-25
ODTX Director — $22.17 — $0 1 2026-05-11
STOK Chief Executive Officer — $32.23 — $0 5 2026-02-19
VRTX EVP, COO 75,380 $523.91 $39.49M -$162.37M 74 2018-07-03
Acorda Therapeutics, Inc. (ACOR) Delisted Director 0 $0.66 $0 -$1.58M 16 2018-06-29
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director 45,845 $0.04 $2.0K $0 12 2018-06-14
IVERIC bio, Inc. (OPHT) Delisted Director — — — $0 1 2016-08-04
EPIX Pharmaceuticals, Inc. (EPIX) Delisted Director — $0.20 — $0 2 2008-05-21

Recent Filings

150 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 SLDB Exer (M) +3,440 $0 EDGAR
2026-06-25 FHTX Grant (A) — $0 EDGAR
2026-06-11 SLDB Grant (A) — $0 EDGAR
2026-05-11 ODTX Grant (A) — $0 EDGAR
2026-04-02 SLDB Exer (M) +3,441 $0 EDGAR
2026-02-19 STOK Grant (A) — $0 EDGAR
2026-01-07 SLDB Mixed +4,573 $0 EDGAR
2025-10-14 STOK Grant (A) — $0 EDGAR
2025-10-07 SLDB Exer (M) +4,573 $0 EDGAR
2025-07-08 SLDB Exer (M) +4,573 $0 EDGAR
Showing 1–10 of 150
Page 1 of 15
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.